A Win For Anavex Life Sciences Corp.

Wed, Dec 04, 2019 at 05:30 PM

Anavex Life Sciences Corp. (AVXL:NASDAQ) jumped higher at $3.03, representing a gain of 28.4%. On Tue 03 Dec 19, AVXL:NASDAQ touched a New 2-Week Intraday Low of $2.26. The stock got featured on our News Catalysts scanner on Wed 04 Dec 19 at 10:23 AM in the 'BIOTECH' category.

About Anavex Life Sciences Corp. (AVXL:NASDAQ)

Anavex Life Sciences Corp is a clinical stage bio-pharmaceutical company. The Company is engaged in the developments drug candidates to treat Alzheimer's disease, other central nervous system (CNS) diseases, and various types of cancer.

Top 10 Gainers:

Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 72.92%
iBio, Inc. (IBIO:NYSEMKT), 51.06%
Kodiak Sciences Inc. (KOD:NASDAQ), 49.21%
Allakos Inc. (ALLK:NASDAQ), 43.56%
Jason Industries, Inc. (JASN:NASDAQ), 41.44%
Anavex Life Sciences Corp. (AVXL:NASDAQ), 28.39%
Comstock Mining Inc. (LODE:NYSEMKT), 27.71%
Obsidian Energy Ltd. (OBE:NYSE), 22.55%
Applied Therapeutics, Inc. (APLT:NASDAQ), 21.7%
Neurotrope, Inc. (NTRP:NASDAQ), 21.3%